Meningioma 1 Antikörper (Middle Region)
-
- Target Alle Meningioma 1 (MN1) Antikörper anzeigen
- Meningioma 1 (MN1) (MN1 proto-oncogene (MN1))
-
Bindungsspezifität
- AA 842-872, Middle Region
-
Reaktivität
- Human
-
Wirt
- Kaninchen
-
Klonalität
- Polyklonal
-
Konjugat
- Dieser Meningioma 1 Antikörper ist unkonjugiert
-
Applikation
- Western Blotting (WB), Enzyme Immunoassay (EIA)
- Spezifität
- This antibody recognizes Human MN1 (Center).
- Aufreinigung
- Protein A column, followed by peptide affinity purification
- Immunogen
- KLH conjugated synthetic peptide between 842-872 amino acids from the Central region of human MN1.
- Isotyp
- Ig Fraction
- Top Product
- Discover our top product MN1 Primärantikörper
-
-
- Applikationshinweise
- Optimal working dilution should be determined by the investigator.
- Beschränkungen
- Nur für Forschungszwecke einsetzbar
-
- Format
- Liquid
- Konzentration
- 0.25 mg/mL
- Buffer
- PBS containing 0.09 % (W/V) Sodium Azide as preservative
- Konservierungsmittel
- Sodium azide
- Vorsichtsmaßnahmen
- This product contains sodium azide: a POISONOUS AND HAZARDOUS SUBSTANCE which should be handled by trained staff only.
- Handhabung
- Avoid repeated freezing and thawing.
- Lagerung
- 4 °C/-20 °C
- Informationen zur Lagerung
- Store undiluted at 2-8 °C for one month or (in aliquots) at -20 °C for longer.
-
- Target
- Meningioma 1 (MN1) (MN1 proto-oncogene (MN1))
- Andere Bezeichnung
- MN1 (MN1 Produkte)
- Synonyme
- MGCR antikoerper, MGCR1 antikoerper, MGCR1-PEN antikoerper, dJ353E16.2 antikoerper, MN1 proto-oncogene, transcriptional regulator antikoerper, MN1 antikoerper
- Hintergrund
- Meningioma 1 (MN1) contains two sets of CAG repeats. It is disrupted by a balanced translocation (4,22) in a meningioma, and its inactivation may contribute to meningioma 32 pathogenesis.Synonyms: Probable tumor suppressor protein MN1, meningioma 1
- Molekulargewicht
- 136001 Da
- Gen-ID
- 4330
- NCBI Accession
- NP_002421
-